Blue Jet Healthcare Ltd (BLUEJET) is currently trading at 504.35 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Blue Jet Healthcare is a Mumbai‑headquartered, science‑led CDMO and specialty chemicals manufacturer focused on contrast media intermediates, high‑intensity sweeteners and pharma intermediates/APIs, operating multiple manufacturing units and expanding into integrated R&D and commercial GMP manufacturing to support global innovator partnerships. Q1 FY27 operational performance improved with turnover of INR293 crores, a 25% sequential increase, reported gross margin at 53% (down ~3 percentage points) and operating EBITDA at 33.5% (up ~3 percentage points), reflecting product mix shifts, improved PI/API demand and transit-related timing that deferred roughly INR30 crores of revenue into the next quarter. Blue Jet Healthcare is accelerating its CDMO capabilities by commissioning an on‑site Hyderabad R&D center and designing Vizag as an integrated manufacturing and innovation platform; management expects three contrast media candidates to be launched in FY27 while piloting a new high‑intensity sweetener and tracking multiple high‑conviction NCE opportunities. The company highlights sustainability progress with roughly 70% renewable energy consumption, an EcoVadis Silver medal and a CII National Award for Excellence in Energy Management, and management frames the completed QIP as strengthening the balance sheet to fund strategic capex and long‑term growth ambitions.

Over the past 52 weeks, Blue Jet Healthcare Ltd has traded between a low of ₹325.20 and a high of ₹688.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Blue Jet Healthcare Ltd has a market capitalization of approximately 9,536.66. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Blue Jet Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 40.60 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 9,536.66 Cr, Blue Jet Healthcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Blue Jet Healthcare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Blue Jet Healthcare Ltd is 40.60. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The board recommended a final dividend of ₹1.20 per equity share (face value ₹2) for FY26, subject to shareholder approval at the AGM.

Total revenue was ₹354.76 crore, up from ₹234.67 crore in the preceding March quarter and ₹162.90 crore in the year-ago June quarter.

The upcoming earnings date is stated as 25th May, 2026 in the provided data.

Blue Jet Healthcare launched a qualified institutional placement (QIP) to raise funds from institutional investors, with media reports indicating a target of around ₹600 crore.